Julia G. Butchko, Chief Development Officer at Immunovant, Inc. (IMVT), sold 3,174 shares at $36.39 ($115K) on 2023-10-05, disclosed to the SEC on 2023-10-06.
Open-market sale of $115k IMVT by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.54 | 296 | $11K | 9.1% |
| 2 | $36.39 | 1,439 | $52K | 45.4% |
| 3 | $36.39 | 1,439 | $52K | 45.4% |
| Total | $36.31 avg | 3,174 | $115K | 100% |
| Filing → |
| IMVT | SELL | 2024-07-10 | $43K | — | Filing → |
| IMVT | SELL | 2024-05-24 | $193K | — | Filing → |
| IMVT | SELL | 2024-04-19 | $362K | — | Filing → |